Here’s What the Street Thinks About Eli Lilly and Company (LLY) - Yahoo Finance
Here’s What the Street Thinks About Eli Lilly and Company (LLY) Yahoo Finance
Eli Lilly Company News
Eli Lilly suspends access to drug discounts for some hospitals - Indiana Capital Chronicle
Eli Lilly suspends access to drug discounts for some hospitals Indiana Capital Chronicle
Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it? - statnews.com
Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it? statnews.com
China approval for Eli Lilly GLP-1 pill to come as soon as 2026, executive says - Reuters
China approval for Eli Lilly GLP-1 pill to come as soon as 2026, executive says Reuters
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders - PR Newswire
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders PR Newswire
Why Is Eli Lilly (LLY) Stock Soaring Today - StockStory
Why Is Eli Lilly (LLY) Stock Soaring Today StockStory
Obesity drugs approach a major milestone, and Lilly may have a 'game changer' ahead - CNBC
Obesity drugs approach a major milestone, and Lilly may have a 'game changer' ahead CNBC
Here’s What the Street Thinks About Eli Lilly and Company (LLY) - Insider Monkey
Here’s What the Street Thinks About Eli Lilly and Company (LLY) Insider Monkey
Eli Lilly stock hits all-time high at 1183.0 USD - Investing.com
Eli Lilly stock hits all-time high at 1183.0 USD Investing.com
Flush with GLP-1 cash, Eli Lilly is on a Greater Boston shopping spree - The Business Journals
Flush with GLP-1 cash, Eli Lilly is on a Greater Boston shopping spree The Business Journals
Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts - MedCity News
Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts MedCity News
Eli Lilly & Co (NYSE:LLY) Screens as a Top Growth Stock with a Strong Technical Breakout Setup - ChartMill
Eli Lilly & Co (NYSE:LLY) Screens as a Top Growth Stock with a Strong Technical Breakout Setup ChartMill
Is It Too Late to Buy Eli Lilly and Co (LLY) After 7.1% Rally? G - GuruFocus
Is It Too Late to Buy Eli Lilly and Co (LLY) After 7.1% Rally? G GuruFocus
Eli Lilly says Trump pricing policy will affect obesity drug launches in Europe - Reuters
Eli Lilly says Trump pricing policy will affect obesity drug launches in Europe Reuters
Trump name-dropped Nokia and Eli Lilly in a Pennsylvania speech. Here's what happened to 5 other stocks he singled out - Yahoo Finance
Trump name-dropped Nokia and Eli Lilly in a Pennsylvania speech. Here's what happened to 5 other stocks he singled out Yahoo Finance
Eli Lilly dives into hair loss treatments with investment in AI startup Absci - statnews.com
Eli Lilly dives into hair loss treatments with investment in AI startup Absci statnews.com
Portland-area biotech receives $100M investment led by Eli Lilly - The Business Journals
Portland-area biotech receives $100M investment led by Eli Lilly The Business Journals
At BIO, a glimpse behind Lilly and Chai’s partnership - statnews.com
At BIO, a glimpse behind Lilly and Chai’s partnership statnews.com
Nancy Pelosi Stock Tracker Flags Eli Lilly, Nokia After Trump Praise: ‘Keep An Eye On These Two’ - Yahoo Finance
Nancy Pelosi Stock Tracker Flags Eli Lilly, Nokia After Trump Praise: ‘Keep An Eye On These Two’ Yahoo Finance
Fact check: Who did Eli Lilly give access to its obesity drug? White House says not Trump - Yahoo
Fact check: Who did Eli Lilly give access to its obesity drug? White House says not Trump Yahoo
Eli Lilly and Co Stock (LLY) Moved Up by 6.15% on Jun 26: Drivers Behind the Movement - TradingKey
Eli Lilly and Co Stock (LLY) Moved Up by 6.15% on Jun 26: Drivers Behind the Movement TradingKey
Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials | Eli Lilly and Company - investor.lilly.com
Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials | Eli Lilly and Company investor.lilly.com
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors - Yahoo Finance
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors Yahoo Finance
Investigating claim Trump got exclusive access to potent obesity drug retatrutide - Snopes
Investigating claim Trump got exclusive access to potent obesity drug retatrutide Snopes
The Investment Case for Eli Lilly and Co (LLY): How Financial Gr - GuruFocus
The Investment Case for Eli Lilly and Co (LLY): How Financial Gr GuruFocus
Eli Lilly, Novo Both Share Good News on Weight-Loss Drugs. Only One Stock Is Rising. - Barron's
Eli Lilly, Novo Both Share Good News on Weight-Loss Drugs. Only One Stock Is Rising. Barron's
Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data - statnews.com
Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data statnews.com
Eli Lilly (LLY) Acquires Centessa Pharmaceuticals to Advance Orexin Receptor 2 Agonists - Insider Monkey
Eli Lilly (LLY) Acquires Centessa Pharmaceuticals to Advance Orexin Receptor 2 Agonists Insider Monkey
Market movers: Triller Group, Eli Lilly, Onsemi… - Proactive financial news
Market movers: Triller Group, Eli Lilly, Onsemi… Proactive financial news
Lilly announces three acquisitions to build infectious disease portfolio - PR Newswire
Lilly announces three acquisitions to build infectious disease portfolio PR Newswire
Eli Lilly, Google Lead Five Stocks To Watch - Investor's Business Daily
Eli Lilly, Google Lead Five Stocks To Watch Investor's Business Daily
Eli Lilly issues data sharing ultimatum to 340B hospitals - Healthcare Dive
Eli Lilly issues data sharing ultimatum to 340B hospitals Healthcare Dive
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines - PR Newswire
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines PR Newswire
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors - The Motley Fool
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors The Motley Fool
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas - CNBC
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas CNBC
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions - investor.lilly.com
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions investor.lilly.com
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes - investor.lilly.com
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes investor.lilly.com
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage - CNBC
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage CNBC
Eli Lilly and Company’s (LLY) Foundayo and Zepbound Set To Be Covered for Millions of Americans - Yahoo Finance
Eli Lilly and Company’s (LLY) Foundayo and Zepbound Set To Be Covered for Millions of Americans Yahoo Finance
A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk. - Yahoo Finance
A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk. Yahoo Finance